Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Published byGerard Cooper Modified over 7 years ago

Similar presentations

Presentation on theme: "Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological."— Presentation transcript:

1 Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis B. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged StageDefinition AcuteDetection of IgM antigen-specific antibody (anti-HBc IgM) or Detection of hepatitis surface antigen (HBsAg) and previous negative HBV markers less than six months ago or Detection of hepatitis B nucleic acid (HBV-DNA) and previous negative HBV markers less than six months ago Any of the above with or without symptoms and signs (e.g. jaundice, elevated serum aminotransferase levels, fatigue, abdominal pain, loss of appetite, intermittent nausea, vomiting, fever) ChronicDetection of HBsAg or HBeAg or HBV-DNA and No detection of anti-HBc IgM (negative result) or Detection of HBsAg or HBeAg or HBV-DNA on two occasions that are six months apart* UnknownAny newly diagnosed case which cannot be classified in accordance with the above definition of acute or chronic infection

2 Table 2. Number and rate of reported hepatitis B cases per 100 000 population, EU/EEA, 2010–2014 † † Data presented by date of diagnosis. * Includes the cases reported by countries as acute, chronic or unknown using the differentiation criteria ** Excludes data from Scotland Source: Country reports Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis B. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged 20102011201220132014 Country All Acute*Chronic*Unknown* CasesRateCasesRateCasesRateCasesRateCasesRateCasesRateCasesRateCasesRate Austria7338.875698329.96707.9116513.7740.95826.85096 Belgium 1627 Bulgaria3875.23444.73224.43024.12353.2 Croatia 1363.21363.21493.5 Cyprus70.9101.2141.69140.5 4 Czech Republic2442.31911.81541.51331.31051 1 Denmark1703.12644.72985.32835.12314.1170.32113.730.1 Estonia584.4443.3513.8362.7332.580.6251.9 Finland2785.22474.62494.62684.92765.1190.32574.7 France910.11020.21000.2830.1930.1930.1 Germany7630.981016860.86840.87400.95780.7 1620.2 Greece350.3380.3500.5320.3270.2270.2 Hungary600.6670.7530.5620.6650.7650.7 Iceland299.1257.9206.3165288.630.9 257.7 Ireland64914.352311.457112.54299.34229.2280.63838.3110.2 Italy7091.26791.15610.95050.81400.2 1400.2 Latvia32215.231815.332916.13031526213.1623.120010 Lithuania712.3602230.8351.2260.9260.9 Luxembourg183.6163.1265387.1325.810.2112203.6 Malta204.8358.4184.3174225.200214.910.2 Netherlands179410.8173510.415259.113057.812157.21410.810656.390.1 Norway76415.776315.570614.273814.669513.6220.467313.2 Poland1280.31040.3780.215414680.2680.2 Portugal160.2260.2280.3240.2480.5190.2 290.3 Romania4862.441223611.83021.52661.32471.2190.1 Slovakia2093.91713.21592.91943.61823.4811.51011.9 Slovenia422.1713.5412522.5391.9120.6271.3 Spain6621.45221.15251.16451.46331.46331.4 Sweden158917138914.8160616.9167317.5190919.81061.1166717.31361.4 United Kingdom**603610.5787613.6876115914915.61170519.83370.6912915.422393.8 Total EU/EEA163703.4175983.6182833.7196644.0224424.226670.6143719.850201.3

3 Figure 1. Rate of reported acute hepatitis B cases* per 100 000 population, EU/EEA, 2014 Source: Country reports from Austria, Bulgaria, Cyprus, Denmark, Estonia, Finland, France**, Germany, Greece, Hungary, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom***. * Countries were included if they were able to present data by disease status or they used a case definition that included only acute cases (e.g. EU 2008). ** Underreporting of acute hepatitis B in France was estimated at 76.5% in 2013. *** UK data exclude Scotland Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis B. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

4 Figure 2. Rate of acute and chronic hepatitis B cases per 100 000 population, EU/EEA, 2006–2014 Note: Logarithmic scale Source: Country reports from Austria, Bulgaria, Cyprus, Denmark, Estonia, Finland, France*, Germany, Greece, Hungary, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom**. * Underreporting of acute hepatitis B in France was estimated at 76.5% in 2013. ** UK data exclude Scotland. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis B. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

5 Figure 3. Rate of reported acute and chronic hepatitis B cases per 100 000 population, by age group, EU/EEA, 2014 Source: Country reports from Austria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France*, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom**. * Underreporting of acute hepatitis B in France was estimated at 76.5% in 2013. ** UK data exclude Scotland Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis B. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

6 Figure 4. Rate of reported acute hepatitis B cases per 100 000 population, by age group and gender, EU/EEA, 2014 Source: Country reports from Austria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France*, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom**. * Underreporting of acute hepatitis B in France was estimated at 76.5% in 2013. ** UK data exclude Scotland Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis B. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

7 Figure 5. Transmission category of hepatitis B cases by acute and chronic disease status, EU/EEA, 2014* Source: Country reports from Austria, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, and the United Kingdom**. * Among cases where transmission status is known ** UK data exclude Scotland Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis B. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

8 Table. Hepatitis B, surveillance systems overview, 2014 Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A) Data reported by: laboratories (L), physicians (P), hospitals (H), other (O) Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2016. Hepatitis B. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged Surveillance Data reported byCase definition used characteristics CountryData source LPHO AustriaAT-EpidemiegesetzCoC YYYYEU-2008 BelgiumBE-LABNETSeCYN..Other BulgariaBG-NATIONAL_SURVEILLANCECoA YYYYEU-2008 CroatiaHR-CNIPHCoAYYYYEU-2012 CyprusCY-NOTIFIED_DISEASESCoC NYNNEU-2008 Czech Republic CZ-EPIDATCoCNYYNEU-2012 DenmarkDK-MISCoC NYNNOther EstoniaEE-NAKISCoCYYYNEU-2012 FinlandFI-NIDRCoC YYNNEU-2012 FranceFR-MANDATORY_INFECTIOUS_DISEASESCoCYYYYEU-2012 GermanyDE-SURVNET@RKI-7.1/6CoC YYYYOther GreeceEL-NOTIFIABLE_DISEASESCoCYYYNEU-2008 HungaryHU-EFRIRCoC YYYNEU-2012 IcelandIS-SUBJECT_TO_REGISTRATIONCoCYYYNEU-2012 IrelandIE-CIDRCoC YYYNEU-2012 ItalyIT-NRSCoCNYYNOther ItalyIT-SEIEVASeC NYYNEU-2012 LatviaLV-BSNCoCYYYYEU-2012 LithuaniaLT-COMMUNICABLE_DISEASESCoC NYNNEU-2012 LuxembourgLU-SYSTEM1CoCNYNNOther MaltaMT-DISEASE_SURVEILLANCECoC YYYYEU-2012 NetherlandsNL-OSIRISCoCYYNNEU-2012 NorwayNO-MSIS_ACoC YYYNEU-2012 PolandPL-NATIONAL_SURVEILLANCECoCNYYNEU-2008 PortugalPT-HEPATITISBCoC NYNNOther RomaniaRO-RNSSyCoCYNYNOther SlovakiaSK-EPISCoC YYYNEU-2012 SloveniaSI-SURVIVALCoCYYYNEU-2012 SpainES-STATUTORY_DISEASESCoC NYYNEU-2012

Download ppt "Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological."

Similar presentations

THE EUROPEAN UNION. HISTORY 28 European states after the second world war in 1951 head office: Brussels 24 different languages Austria joined 1995.

THE EUROPEAN UNION. HISTORY 28 European states after the second world war in 1951 head office: Brussels 24 different languages Austria joined 1995.
Map - Region 3 Europe.

Map - Region 3 Europe.
Time line By: Shirley Lin. The story of European Union 1945 1951 19571973 1981 1986 19921995 2004 2007.

Time line By: Shirley Lin. The story of European Union
Table 1. Numbers and rates of TB cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:

Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,

Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Number and rate of Legionnaires’ disease cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.

Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.
CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.

CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.
Surveillance of hepatitis B and C in the EU/EEA

Surveillance of hepatitis B and C in the EU/EEA
  Surveillance Data reported by Case definition used characteristics

  Surveillance Data reported by Case definition used characteristics
EUROPEAN UNION – MAKING OFF European Economic Community

EUROPEAN UNION – MAKING OFF European Economic Community
Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Achieving WHO Recommendations for HCV in the European Union

Achieving WHO Recommendations for HCV in the European Union
Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014

Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014
Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.

Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.
European Union Duy Trinh.

European Union Duy Trinh.
Table 1. Reported confirmed hepatitis A cases: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
DISTRIBUTION AUTOMATIC - GENERATION

DISTRIBUTION AUTOMATIC - GENERATION
Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011.

Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per population, EU/EEA, 2010–2014 Country
Country 2010 2011 2012 2013 2014 Cases Rate National data Report type

Country Cases Rate National data Report type

Similar presentations

Ads by Google